Ascendis Health Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ascendis Health Ltd with three other
pharmaceutical manufacturers in Africa:
sales of 511.20 million Moroccan Dirhams [US$55.77 million]
Glaxo Smithkline Consumer Nigeria PLC
(16.09 billion Naira [US$52.61 million]
Societe De Therapeutique Marocaine
based in Morocco
(1.42 billion Moroccan Dirhams [US$154.38 million]
of which 100%
was Drug Manufactures).
Ascendis Health Ltd reported sales of 6.44 billion South African Rands (US$533.91 million)
June of 2017.
increase of 64.2%
versus 2016, when the company's sales were 3.92 billion South African Rands.
Sales at Ascendis Health Ltd have increased during each of the previous five years
(and since 2012, sales have increased a total of 1,803%).
Sales of Consumer Brands saw an increase
that was more than double the company's growth rate: sales were up
134.6% in 2017, from
921.84 million South African Rands to 2.16 billion South African Rands.
Ascendis Health Ltd also saw significant increases in sales in
Pharma-Med (up 96.8% to 3.56 billion South African Rands)